Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.872 USD | +1.92% | +0.49% | -57.60% |
Apr. 16 | Scilex Issues Preliminary Q1 Sales Results for ZTlido | MT |
Mar. 20 | Scilex Seeks FDA Approval to Add Dosing Guidance to Gout Treatment Drug Label | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.60% | 104M | |
+4.30% | 69.17B | |
+12.55% | 9.06B | |
-12.75% | 4.96B | |
+42.38% | 4.47B | |
+5.23% | 3.9B | |
+21.52% | 2.41B | |
-19.05% | 2.41B | |
-28.72% | 2.23B | |
+11.13% | 2.02B |
- Stock Market
- Equities
- SCLX Stock
- News Scilex Holding Company
- Scilex Settles Claims in Case Against Virpax for $6 Million, 6% Royalties From Three Drugs